Pharmedium Services, LLC recalls Neostigmine Methylsulfate Injection in all strengths, all doses, and all packaging.
- Recall date
- December 27, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0461-2018
- FDA classification
- Class II
- Brand / firm
- Pharmedium Services, LLC
- Sold / distributed
- U.S.A. Nationwide
Why it was recalled
Lack of sterility assurance.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Neostigmine Methylsulfate Injection in all strengths, all doses, and all packaging.
Get recall alerts
Free email alert whenever Pharmedium Services, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Pharmedium Services, LLC